These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17134653)

  • 1. Targeting of toxic compounds to the trypanosome's interior.
    Barrett MP; Gilbert IH
    Adv Parasitol; 2006; 63():125-83. PubMed ID: 17134653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-interference silencing of the adenosine transporter-1 gene in Trypanosoma evansi confers resistance to diminazene aceturate.
    Witola WH; Inoue N; Ohashi K; Onuma M
    Exp Parasitol; 2004; 107(1-2):47-57. PubMed ID: 15208037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel functionalized melamine-based nitroheterocycles: synthesis and activity against trypanosomatid parasites.
    Baliani A; Peal V; Gros L; Brun R; Kaiser M; Barrett MP; Gilbert IH
    Org Biomol Chem; 2009 Mar; 7(6):1154-66. PubMed ID: 19262935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance in human African trypanosomiasis.
    Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E
    Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance.
    Lanteri CA; Stewart ML; Brock JM; Alibu VP; Meshnick SR; Tidwell RR; Barrett MP
    Mol Pharmacol; 2006 Nov; 70(5):1585-92. PubMed ID: 16912218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of a series of melamine-based nitroheterocycles with activity against Trypanosomatid parasites.
    Baliani A; Bueno GJ; Stewart ML; Yardley V; Brun R; Barrett MP; Gilbert IH
    J Med Chem; 2005 Aug; 48(17):5570-9. PubMed ID: 16107157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pharmacology of adenosine transport in Trypanosoma brucei: P1/P2 revisited.
    Geiser F; Lüscher A; de Koning HP; Seebeck T; Mäser P
    Mol Pharmacol; 2005 Sep; 68(3):589-95. PubMed ID: 15933219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.
    Scott AG; Tait A; Turner CM
    Exp Parasitol; 1997 Jul; 86(3):181-90. PubMed ID: 9225768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake and mode of action of drugs used against sleeping sickness.
    Denise H; Barrett MP
    Biochem Pharmacol; 2001 Jan; 61(1):1-5. PubMed ID: 11137702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes.
    de Koning HP
    Trends Parasitol; 2008 Aug; 24(8):345-9. PubMed ID: 18599351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transporters of Trypanosoma brucei-phylogeny, physiology, pharmacology.
    Schmidt RS; Macêdo JP; Steinmann ME; Salgado AG; Bütikofer P; Sigel E; Rentsch D; Mäser P
    FEBS J; 2018 Mar; 285(6):1012-1023. PubMed ID: 29063677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diamidines for human African trypanosomiasis.
    Paine MF; Wang MZ; Generaux CN; Boykin DW; Wilson WD; De Koning HP; Olson CA; Pohlig G; Burri C; Brun R; Murilla GA; Thuita JK; Barrett MP; Tidwell RR
    Curr Opin Investig Drugs; 2010 Aug; 11(8):876-83. PubMed ID: 20721830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs and drug resistance in African trypanosomiasis.
    Delespaux V; de Koning HP
    Drug Resist Updat; 2007; 10(1-2):30-50. PubMed ID: 17409013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death.
    Delgado M; Anderson P; Garcia-Salcedo JA; Caro M; Gonzalez-Rey E
    Cell Death Differ; 2009 Mar; 16(3):406-16. PubMed ID: 19057622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple genetic mechanisms lead to loss of functional TbAT1 expression in drug-resistant trypanosomes.
    Stewart ML; Burchmore RJ; Clucas C; Hertz-Fowler C; Brooks K; Tait A; Macleod A; Turner CM; De Koning HP; Wong PE; Barrett MP
    Eukaryot Cell; 2010 Feb; 9(2):336-43. PubMed ID: 19966032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fluorescence-based assay for the uptake of CPD0801 (DB829) by African trypanosomes.
    Ward CP; Burgess KE; Burchmore RJ; Barrett MP; de Koning HP
    Mol Biochem Parasitol; 2010 Dec; 174(2):145-9. PubMed ID: 20637807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenical-resistant trypanosomes lack an unusual adenosine transporter.
    Carter NS; Fairlamb AH
    Nature; 1993 Jan; 361(6408):173-6. PubMed ID: 8421523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanocidal drugs: mechanisms, resistance and new targets.
    Wilkinson SR; Kelly JM
    Expert Rev Mol Med; 2009 Oct; 11():e31. PubMed ID: 19863838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes.
    Barrett MP; Fairlamb AH
    Parasitol Today; 1999 Apr; 15(4):136-40. PubMed ID: 10322334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.